LACK OF CORRELATION BETWEEN ACTIVATED CLOTTING TIME AND PLASMA HEPARIN DURING CARDIOPULMONARY BYPASS

被引：150
|
作者：
CULLIFORD, AT
GITEL, SN
STARR, N
THOMAS, ST
BAUMANN, FG
WESSLER, S
SPENCER, FC
机构：
[1] NYU,SCH MED,DEPT MED,NEW YORK,NY 10016
[2] NYU,SCH MED,DEPT ANESTHESIOL,NEW YORK,NY 10016
来源：
ANNALS OF SURGERY | 1981年 / 193卷 / 01期
关键词：
D O I：
10.1097/00000658-198101000-00017
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：105 / 111
页数：7
相关论文
共 50 条
  • [1] ACTIVATED CLOTTING TIME AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    SWAANENBURG, JCJM
    BRENKEN, U
    BAKKER, HAM
    [J]. CLINICAL CHEMISTRY, 1990, 36 (06) : 975 - 975
  • [2] CORRELATION OF PLASMA HEPARIN LEVELS WITH AUTOMATED CLOTTING TIMES DURING CARDIOPULMONARY BYPASS
    BUTT, RW
    LEBLANC, P
    DERMODY, L
    [J]. CANADIAN JOURNAL OF MEDICAL TECHNOLOGY, 1980, 42 (03): : 83 - 84
  • [3] MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME
    BERG, E
    STENBJERG, S
    ALBRECHTSEN, OK
    [J]. JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY, 1979, 11 (06): : 229 - 235
  • [4] Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass
    Takashi Watanabe
    Kazuaki Shirota
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (6): : 530 - 530
  • [5] MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, H
    YACOUB, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1025 - 1025
  • [6] THE ROLE OF THE ACTIVATED CLOTTING TIME IN HEPARIN ADMINISTRATION AND NEUTRALIZATION FOR CARDIOPULMONARY BYPASS
    ESPOSITO, RA
    CULLIFORD, AT
    COLVIN, SB
    THOMAS, SJ
    LACKNER, H
    SPENCER, FC
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1983, 85 (02): : 174 - 185
  • [7] GUIDELINES FOR MONITORING HEPARIN BY THE ACTIVATED CLOTTING TIME WHEN APROTININ IS USED DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, HC
    YACOUB, M
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 104 (01): : 211 - 212
  • [8] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS IN MAN - USE OF FLUOROGENIC HEPARIN ASSAY TO VALIDATE ACTIVATED CLOTTING TIME
    HUGHES, DR
    FAUST, RJ
    DIDISHEIM, P
    TINKER, JH
    [J]. ANESTHESIA AND ANALGESIA, 1982, 61 (02): : 189 - 190
  • [9] CLINICAL-EXPERIENCE WITH THE ACTIVATED CLOTTING TIME FOR THE CONTROL OF HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS
    AKL, BF
    VARGAS, GM
    NEAL, J
    ROBILLARD, J
    KELLY, P
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1980, 79 (01): : 97 - 102
  • [10] Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration
    Koerber, JM
    Smythe, MA
    Begle, RL
    Mattson, JC
    Kershaw, BP
    Westley, SJ
    [J]. PHARMACOTHERAPY, 1999, 19 (08): : 922 - 931
12345